Avis n° 2017.0099/AC/SEAP du 30 novembre 2017 du collège de la Haute Autorité de santé relatif à la prise en charge dérogatoire prévue à l’article L. 165-1-1 du code de la sécurité sociale du test diagnostique METAglut1 METAFORA biosystems
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
8gsL83qA6rdEjp2T